PIK3IP1
Appearance
| PIK3IP1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aliases | PIK3IP1, HGFL, hHGFL(S), phosphoinositide-3-kinase interacting protein 1, TrIP | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| External IDs | MGI: 1917016; GeneCards: PIK3IP1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Wikidata | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Phosphoinositide-3-kinase-interacting protein 1 (PIK3IP1) is an enzyme that in humans is encoded by the PIK3IP1 gene.[4][5]
PIK3IP1 is a transmembrane protein that binds to PI3K, reducing signal to the PI3K/AKT/mTOR pathway.[6] Through this mechanism, PIK3IP1 inhibits cell proliferation in tumor cells and is associated with cancer. PIK3IP1 is also associated with the inflammatory response and autoimmune diseases.[6]
References
[edit]- 1 2 3 GRCh38: Ensembl release 89: ENSG00000100100 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, et al. (December 2002). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proceedings of the National Academy of Sciences of the United States of America. 99 (26): 16899–16903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- ↑ "Entrez Gene: MGC17330 HGFL gene".
- 1 2 Jia Y, He P, Ma X, Lv K, Liu Y, Xu Y (August 2024). "PIK3IP1: structure, aberration, function, and regulation in diseases". European Journal of Pharmacology. 977 176753. doi:10.1016/j.ejphar.2024.176753. PMID 38897445.
Further reading
[edit]- Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery". Genome Research. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID 8889548.
- Collins JE, Goward ME, Cole CG, Smink LJ, Huckle EJ, Knowles S, et al. (January 2003). "Reevaluating human gene annotation: a second-generation analysis of chromosome 22". Genome Research. 13 (1): 27–36. doi:10.1101/gr.695703. PMC 430954. PMID 12529303.
- Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites". Protein Science. 13 (10): 2819–2824. doi:10.1110/ps.04682504. PMC 2286551. PMID 15340161.
- Collins JE, Wright CL, Edwards CA, Davis MP, Grinham JA, Cole CG, et al. (2004). "A genome annotation-driven approach to cloning the human ORFeome". Genome Biology. 5 (10) R84. doi:10.1186/gb-2004-5-10-r84. PMC 545604. PMID 15461802.
- Otsuki T, Ota T, Nishikawa T, Hayashi K, Suzuki Y, Yamamoto J, et al. (2005). "Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries". DNA Research. 12 (2): 117–126. doi:10.1093/dnares/12.2.117. PMID 16303743.
- Zhu Z, He X, Johnson C, Stoops J, Eaker AE, Stoffer DS, et al. (June 2007). "PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein". Biochemical and Biophysical Research Communications. 358 (1): 66–72. doi:10.1016/j.bbrc.2007.04.096. PMC 1978172. PMID 17475214.